‘Well, it’s now 2023 and the private sector is indeed getting ready for that transition. And for Moderna, the pharmaceutical and biotech company based in Cambridge, that means more than quadrupling the price of its COVID vaccine — from the $26 per dose it charged the federal government in their latest contract to somewhere between $110 and $130 per dose on the commercial market. ‘